ProCE Banner Activity

Longitudinal Cohort Study Demonstrates Notable Rate of > 3% BMD Loss Over 2 Yrs Among MSM Receiving TDF-Based PrEP

Slideset Download
Conference Coverage
This small prospective study found that sizeable proportions of MSM (24% to 35%) experienced more than 3% BMD loss in the femur, spine, and hip after 2 years of TDF-based PrEP.

Released: November 19, 2019

Share

Provided by

Provided by the USF Health
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare